Creative Biolabs-Immuno-oncology

Anti-DR6 (clone SI2E1G8PDS) SynExpress E1-G-GR-E Modified CD8+ T cells (CAT#: ITS-1224-CR2302)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DR6 (clone SI2E1G8PDS). We employs the pBR322 (EF1α-GFP-GR-EcoRI) vector components and the SynExpress system of the Exons Deletion/Positive feedback for a robust and sustained response against cancers.
Host
Rabbit
Target
DR6
Clone
SI2E1G8PDS
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
EF1α
Effector Gene
GR
Insertion Sites
EcoRI
Gene Modification
Deletion
Modification Domain
Exons
Carrier Type
pBR322
Transformation Accuracy
0.98
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.